Legionella pneumophila is the most common cause of legionellosis and is one of the organisms causing atypical pneumonia. We report the presentation of disseminated intravascular coagulation (DIC) and skin rash in a single case of severe Legionella pneumonia. The unique clinical presentation of a diffuse rash diagnosed as purpura fulminans and the unpredictable variations encountered during the diagnostic work-up of the case make this write-up crucial. This article synthesizes all reported cases of L. pneumonia associated with cutaneous manifestations as well as cases presenting with DIC. Furthermore, this manuscript illustrates the correlation between cutaneous and coagulopathic manifestations, and morbidity and mortality from L. pneumonia.
Introduction
Cutaneous manifestations in Legionellosis are very uncommon. They may present as maculopapular, erythematous, or petechial skin lesions [1] . About 9 cases thus far have been reported describing a rash associated with Legionella infection. A clear mechanism for the rash was not evident in the majority of them. Another uncommon, but well-described phenomenon associated with Legionella pneumophila and Legionella longbeachae, is disseminated intravascular coagulation (DIC) [2] . Legionella urine antigen testing is the main diagnostic test utilized to detect L. pneumophila. However, it has about a 25e30% false negative rate [3] ; awareness about this is lacking and a failure to cover for organisms like legionella early during the illness may lead to uncontrolled endotoxin-related phenomena such as DIC. We hereby elucidate a complicated case of L. pneumophila accompanied by a clinically visible rash as well as coagulopathy culminating in respiratory failure and shock. We have also extracted data from various reference sources including PUBMED, EMBASE, MEDLINE and Ovid, to provide a consolidated view of all reported cases of legionella associated with cutaneous manifestations and DIC.
Case presentation
A 44-year-old male with a past medical history of hyperlipidemia was brought to the ER with a one-week history of cough, body aches, fever, fatigue and a red maculopapular rash on the inner thighs. At presentation, he was in respiratory failure, underwent emergent endotracheal intubation and mechanical ventilation and was admitted to the medical ICU. Initial chest X-ray and CT scan revealed right middle and lower lobe pneumonia (See Figs. 1 and 2 ). Labs tests showed leukopenia (WBC 1.6x10Eþ09/L) and thrombocytopenia (platelet count 94,000). He was started on broadspectrum antibiotics including vancomycin, ciprofloxacin, metronidazole, and doxycycline. Twenty-four hours into hospitalization, the patient's rash became more confluent, with dark necroticappearing areas (see Fig. 3 ), and spread to involve the arms, legs, trunk, tip of the nose and left ear along with acral cyanosis. Due to concern for infective endocarditis, a trans-thoracic echocardiogram was performed that was reported as negative for any vegetation. Serological testing including viral studies, Lyme antibody (Ab), and Rickettsia Ab were negative. Routine blood, urine, and sputum cultures were also negative. Although the initial Legionella urinary antigen testing was reported negative, subsequent repeat analysis in the ICU was positive. In the ICU, the initial serology titers for legionella serogroup 1 were positive at 1:64 and subsequently 1:1024 during the first week. His antibiotics were then adjusted to include ceftriaxone, doxycycline, and moxifloxacin. Simultaneously, work-up for his rash was undertaken and a biopsy was obtained from his right thigh. Histopathology revealed partial fibrin thrombi in small, superficial vessels as well as larger mid-dermal vessels and fibrinoid degeneration of the vessel walls, overall consistent with a coagulopathy (see Fig 4) . The differential diagnosis included DIC, thrombotic thrombocytopenic purpura (TTP), heparin-induced thrombocytopenia (HIT), and anti-phospholipid antibody syndrome. Subsequent work-up revealed a negative HIT panel. Thrombocytopenia with a normal creatinine was not consistent with TTP. He was finally diagnosed with DIC secondary to Legionella pneumonia based on elevated fibrin split products (FDP) and decreased fibrinogen levels. Under appropriate antibiotic coverage, his clinical status improved. The diffuse rash cleared, and the leukopenia as well as thrombocytopenia resolved. He was extubated later during the ICU course and was discharged home within 2 weeks.
Discussion
Legionnaire's disease was discovered in 1976 after an outbreak of pneumonia at an American Legion convention in Philadelphia. The causative organism was later isolated as L. pneumophila, an aerobic gram-negative rod. Legionellosis comprises of two syndromes, Legionnaire's disease and Pontiac fever. Legionnaire's disease refers to severe pneumonia that can be associated with multi-system disease [4] . Pontiac fever is an acute, self-limited, febrile illness sparing the lungs. About 64 serogroups of L. pneumophila have been identified but serogroup 1 is responsible for 70e90 percent of cases. It is transmitted by the aspiration of water contaminated with Legionella and not by person-to-person contact. This can originate from humidifiers, air conditioning, showers, respiratory therapy equipment, etc. Normally, mucociliary action helps clear Legionella in the upper respiratory tract. Organisms that reach the alveoli are consumed by macrophages, multiply within these cells until rupture, and then infect other macrophages. Legionella causes an acute fibropurulent pneumonia with alveolitis and bronchiolitis [5] . It can later affect other organs of the body like the kidneys, liver, brain, and spleen. Symptoms are non-specific including fever, fatigue, headache, confusion, and lethargy [6] . The causative organism, clinic-radiological dissociation, absence of lobar pneumonia in the early phase and paucity of symptoms seen in bacterial pneumonias make it definable as an atypical pneumonia. The mortality rate in Legionnaire's disease is 5e80% depending on certain risk factors like age, underlying chronic disease, nosocomial infection, and time of initiation of therapy. Treatment should be initiated within eight hours or mortality increases [7] . Thus, early clinical suspicion is important.
Cutaneous manifestations including maculopapular, erythematous, or petechial skin lesions have been reported in about 9 cases of Legionella infection: 2 women with diffuse maculopapular rash who presented with fever, chills, asthenia and dry cough [1] ; a man with encephalopathy, lymphadenopathy and petechial rash during an outbreak of Legionnaires' disease in Port Elizabeth [8] ; a man with painful, non-pruritic, macular, erythematous rash limited to pretibial surfaces of both legs [9] ; an immunosuppressed man with a maculopapular rash with secondary hemorrhage [10] ; two men with macular rash and acute renal failure [11] ; a pediatric case with erythema multiforme [12] and a 65 yr old man with a pruritic rash who signed out against medical advice and was brought back to the hospital in a critical condition before dying [13] . See Table 1 . Our case represents extensive skin involvement associated with severe Legionella infection. The rash was maculopapular and limited to the inner thighs initially but later spread to other parts of the body with cyanosis of the toes; the rash was described as "purpura fulminans". The preceding case reports have pointed out that the pathogenesis of the skin involvement may be directly related to a toxin released by the organism or related to an immune response of the host to the organism. [1] [8e13], On the other hand, the rash described in this case had an initial maculopapular phase followed by a purpuric picture. The biopsy finding of partial fibrin thrombi in superficial vessels as well as larger mid-dermal vessels and fibrinoid degeneration of the vessel walls suggests DIC as the underlying pathophysiology behind the purpuric phase of the rash. It may be reasonable to think that the maculopapular rash may be an early manifestation of circulating legionella endotoxins, which when goes uncontrolled becomes purpuric due to concomitant endotoxin-related DIC. Calza et al. mention two men with Pontiac fever as having had a papular rash referring to a report from Spitalny et al. Review of literature suggests that those 2 cases of Pontiac fever were recorded alongside 72 reports of whirlpool sparelated pseudomonal illness with rash, but were not associated with rash themselves [14, 15] .
An uncommon, but well-described phenomenon associated with L. pneumophila and also a few other species under the genus Legionella including L. longbeachae, is disseminated intravascular coagulation (DIC). There are at least 9 case reports of DIC in legionella infection. See Table 2 . All of them except for one were subclinical in the sense that there were no bleeding or clotting manifestations seen alongside the abnormal DIC panel including platelet count, fibrin split products, and fibrinogen levels. See Table 2 . The case described above is the first of reports to have shown clinical evidence of DIC as skin rash. Miragliotta et al. studied and demonstrated the in vitro effect of various members of the genus Legionella including L. longbeachae on human peripheral mononuclear cells. All the strains tested induced the generation of strong procoagulant activity (tissue factor) when incubated for an extended period of time with pure mononuclear cell suspensions. The production of mononuclear cell procoagulant activity was also observed after the addition of bacteria to citrated whole blood. It was found that Escherichia coli 0111:B4 showed comparable effects, but Staphylococcus aureus was much less effective. These results indicate that the presence of an endotoxin-like substance in the external cell wall of legionellae could contribute to the induction of mononuclear cells [16] . In an article by Matsubara et al., a severe case of Legionella micdadei was accompanied by the presence of DIC. The team of physicians applied endotoxin-eliminating therapy using a polymyxin-B-column (PMX) and continuous hemofiltration (CHF). The patient recovered from critical shock after the start of PMX, which together with continuous hemofiltration alleviated his systemic complications. Although the exact nature of the molecules/agents responsible for fatal systemic complications in Legionnare's disease are not well documented, these findings suggested that some substances removable by PMX and CHF might play an important role in pathogenesis [17] . A case described by Takayanagi et al. was unique from the fact that legionella coinfection with influenza virus was associated with DIC [18] . It appears that only one of the above case reports with DIC (Oldenburger) had bleeding manifestations in the form of postthoracotomy bleeding [19] . None of the cases with DIC had cutaneous manifestations nor did the ones with rash have DIC in the clinical course.
The clinical importance of cutaneous manifestations and its relevance to morbidity and mortality from legionella pneumonia is yet to be determined. Analysis of the above reported cases showed that 4 of 10 cases (40%) with rash were associated with mortality from L. pneumonia and its complications. Until more clarity is gained with regard to the ability to predict who gets DIC associated with legionellosis, it is important to monitor CBC during the first few days of illness to look for subclinical thrombocytopenia followed by coagulopathy profile and DIC panel later as directed by the clinical course. Skin biopsy for the rash associated with legionellosis may prove beneficial so as to help with the etiology.
As indicated above, about 80% of cases are from L. pneumophila serogroup 1. The 20% false negative rate that is seen with urinary legionella antigen testing stems from the above fact and this calls for empiric coverage despite a negative test. The fact that legionella urine antigen positivity can remain for days after initiating broadspectrum antibiotics makes it handy in patients who receive empiric anti-Legionella therapy. Furthermore, it takes only an hour for the urine antigen result to arrive [25] . Cost-effectiveness of urine legionella antigen testing in a public health perspective remains to be shown compared to costs related to morbidity and mortality associated with poorly controlled legionella infection [26] . However, nipping the evil in the bud helps.
Conclusion
A false negative urine legionella antigen test is not uncommon. Therefore, empirical anti-legionella therapy should be continued pending repeat urinary antigen tests and/or serum legionella titers due to the increased mortality seen with delay in initiation of such therapy. Cutaneous involvement with Legionellosis is uncommon and may present in various forms and may be complicated by hemorrhage or the presence of purpura fulminans. The presence of rash in the appropriate setting of laboratory abnormalities 
